About Abyrx
Abyrx is a company based in Irvington (United States) founded in 2013. Abyrx has raised $10 million across 1 funding round from investors including Canaan, BB Biotech Ventures and MedEdge Solutions. Abyrx has completed 1 acquisition, including ORTHOCON. Abyrx offers products and services including MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe. Abyrx operates in a competitive market with competitors including Biom'Up, Prytime Medical Devices, Endomedix, United Health Products and LifeBond, among others.
- Headquarter Irvington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abyrx, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abyrx
Abyrx offers a comprehensive portfolio of products and services, including MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe.
Settable, resorbable hemostatic bone putty for surgical bleeding control.
Water-soluble putty for stopping bone bleeding in medical procedures.
Syringe applicator for precise hemostatic bone putty delivery.
People of Abyrx
Unlock access to complete
Funding Insights of Abyrx
Abyrx has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Abyrx
Abyrx has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, BB Biotech Ventures and MedEdge Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
MedEdge Solutions is focused on pharmacy data and management solutions.
|
Locked | Locked | Locked |
Investor details for Abyrx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abyrx
Abyrx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ORTHOCON.
Investment portfolio details for Abyrx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Resorbable hemostatic bone putty is developed to stop surgical bleeding.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Abyrx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Abyrx
Detailed financials for Abyrx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abyrx Comparisons
Peer comparison for Abyrx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abyrx
Abyrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biom'Up, Prytime Medical Devices, Endomedix, United Health Products and LifeBond, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hemostatic products for surgical applications are developed using collagen-based materials.
|
|
| Locked | Locked | Locked |
Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients
|
|
| Locked | Locked | Locked |
Hydrogel solutions for surgery and wound care are developed.
|
|
| Locked | Locked | Locked |
Medical device for hemostasis during surgical procedures is provided.
|
|
| Locked | Locked | Locked |
Absorbable surgical sealants and hemostats are developed for leakage prevention.
|
Detailed competitors of Abyrx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abyrx
Complete news archive for Abyrx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abyrx
Abyrx was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Abyrx is headquartered in Irvington, United States. It is registered at Irvington, New Jersey, United States.
Abyrx is a funded company, having raised a total of $10M across 1 funding round to date.
Abyrx was founded in 2013 and is headquartered in Irvington, United States. Hemostatic bone putty is developed by the company for use in surgical procedures to control bone bleeding. A portfolio of three FDA-cleared putties, which are resorbable and synthetic without tissue components, is maintained. Over 40 issued and pending patents are held. The HEMASORB Resorbable Hemostatic Bone Putty portfolio was acquired to expand offerings in the medical device sector.
Abyrx's top competitors include Prytime Medical Devices, Arch Therapeutics and Biom'Up.
Abyrx offers MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe.
Abyrx has made 1 acquisition, including ORTHOCON.
Abyrx has 3 investors. Key investors include Canaan, BB Biotech Ventures, and MedEdge Solutions.